1. Home
  2. PED vs ICCM Comparison

PED vs ICCM Comparison

Compare PED & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$0.54

Market Cap

49.1M

Sector

Energy

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.70

Market Cap

45.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PED
ICCM
Founded
N/A
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
45.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PED
ICCM
Price
$0.54
$0.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$1.50
$2.50
AVG Volume (30 Days)
146.5K
374.5K
Earning Date
11-17-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
156.43
N/A
EPS
0.11
N/A
Revenue
$33,244,999.00
$2,975,000.00
Revenue This Year
N/A
$2.92
Revenue Next Year
$305.89
$57.81
P/E Ratio
$5.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.59
52 Week High
$1.00
$1.66

Technical Indicators

Market Signals
Indicator
PED
ICCM
Relative Strength Index (RSI) 52.08 43.77
Support Level $0.43 $0.67
Resistance Level $0.55 $0.72
Average True Range (ATR) 0.04 0.05
MACD 0.01 0.01
Stochastic Oscillator 74.08 67.25

Price Performance

Historical Comparison
PED
ICCM

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: